NEW YORK, May 8 - Bioinformatics company Xpogen today said it has licensed its PathlinX 3.0 gene expression-analysis software to Johns Hopkins Medical Center.
According to Cambridge, Mass.-based Xpogen, the PathlinX software was designed to identify differentially co-expressed genes in two-state method-of-action experiments.
Â
"By creating visual networks of clinical and gene-expression data and integrating these results with more conventional techniques, we will be able to mine the genes that are key to a better understanding of the molecular mechanisms of pulmonary disease," said Joe Garcia, director of pulmonary and critical care Medicine at Johns Hopkins.